Inactive Instrument

News Cornerstone Therapeutics, Inc.

Equities

US21924P1030

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	14-02-28	PU
Cornerstone Therapeutics Inc. Stockholders Approve Merger	14-02-03	MW
Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	14-01-31	MW
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	13-11-20	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	13-10-31	PU
Cornerstone Therapeutics, Inc. : Shareholder Rights Law Firm Johnson & Weaver, LLP, is Investigating the Cornerstone Buyout	13-09-16	BU
Cornerstone Therapeutics, Inc. : Law Firm Brower Piven Announces Investigation of Cornerstone Therapeutics, Inc. Proposed Acquisition	13-09-16	BU
Cornerstone Therapeutics, Inc. : Finkelstein Thompson LLP Announces Investigation of Cornerstone Therapeutics Inc. Buyout	13-09-16	BU
Cornerstone Therapeutics, Inc. : Chiesi Farmaceutici and Cornerstone Therapeutics Announce Agreement for a Merger Transaction in Which Chiesi Will Acquire 100 Percent Ownership of Cornerstone for $9.50 per Share in Cash	13-09-16	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Reports First Quarter 2013 Financial Results	13-09-03	PU
Cornerstone Therapeutics, Inc. : REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call	13-08-03	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Sues to Enforce Its CARDENE(R) I.V. Patents	13-07-24	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2012 Conference Call	13-06-30	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter	13-06-13	PU
Cornerstone Therapeutics, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cornerstone Therapeutics Inc. Shareholders	13-02-25	BU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Acquire EKR Therapeutics, Accelerating Expansion in Hospital Market	12-05-14	PU
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Receives FDA Acceptance for CRTX 080 NDA for Treatment of Hyponatremia	12-03-13	PU
CORNERSTONE THERAP : New Research Indicates Treating Neonatal Respiratory Distress Syndrome with CUROSURF® Results in Lower Rate of Mortality Compared to Competitive Surfactants	11-09-12	BU
CORNERSTONE THERAP : Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call	11-02-18	PR
CORNERSTONE THERAP : Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call	10-10-28	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cornerstone Therapeutics, Inc.

Equities

US21924P1030

Summary

Filters